Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Review of the Literature and Report of a Large Series of Patients Regarding the Association of Other Autoimmune Diseases in Patients With Graves’ Disease (With/Without Graves’ Ophthalmopathy)
authors: Ferrari S, Fallahi P, Ruffilli I, Elia G, Ragusa F, Vita R, Benvenga S, Antonelli Asummary/abstract:
Several studies have reported an association between autoimmune thyroid disorders and other autoimmune disorders. We have focused on the prevalence of autoimmune diseases in subjects affected by Graves’ Disease (GD) with/without Graves’ ophthalmopathy (GO).
Three thousand and two hundred-nine patients with GD were prospectively evaluated regarding the appearance of other autoimmune disorders, with respect to three age (+/- 5 years) and gender, matched (3:1), control groups. We have randomly enrolled control groups from the same general population of which: 1069 subjects without thyroid disorders; 1069 patients with non-toxic multinodular goiter; and 1069 patients having autoimmune thyroiditis. Diagnoses were made by specialists according to the criteria established by the scientific societies.
We have shown a significant increase of the prevalence of autoimmune disorders in GD patients, with respect to the controls for: chronic autoimmune gastritis (CAG), vitiligo (Vit), rheumatoid arthritis, polymyalgia rheumatica (Polym), celiac disease, diabetes type 1, Sjogren disease, multiple sclerosis, systemic lupus erythematosus, sarcoidosis, systemic sclerosis, HCV-related cryoglobulinemia.organization: University of Pisa, Italy; University of Messina, Italy
Teprotumumab, an Insulin-Like Growth Factor-1 Receptor Antagonist Antibody, in the Treatment of Active Thyroid eye D...Thyroid eye disease is a disabling autoi...
Swaraj Bose, MDDr. Swaraj Bose was an Associate Profess...
Emotional Impact of Thyroid Eye Disease by Dr. Alon Kahanahttps://www.youtube.com/watch?v=2wHagc7T...
Mario Salvi, MDDr. Mario Salvi is a specialist in endoc...
Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Communityhttps://www.youtube.com/watch?v=ep3ArKFb...
Brian Chuck Tse, MDBrian Chuck Tse is an Assistant Professo...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.